查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561447

2024-2032 年放射治療市場報告（按類型、應用、最終用戶和地區）

Radiotherapy Market Report by Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2023年全球放射治療IMARC Group規模達68億美元。癌症發病率的上升、技術的進步、腫瘤靶向精度的提高、醫療保健支出的增加以及對放射治療作為非侵入性癌症治療選擇的益處的認知的提高，是為市場成長創造積極前景的一些因素。

放射治療市場分析：

  • 主要市場促進因素：放射治療市場主要是由全球癌症發生率上升所推動的，這創造了對非侵入性、高效治療方案的需求。除此之外，發展中地區醫療保健支出的增加和醫療保健基礎設施的改善（更容易獲得先進的放射治療）正在提振放射治療的需求。
  • 主要市場趨勢：放射治療設備的技術進步，例如調強放射治療（IMRT）和影像導引放射治療（IGRT）的發展，代表了放射治療市場的主要趨勢之一。同時，人工智慧（AI）在放射治療中的整合改善了治療計劃和實施是另一個新興趨勢，導致更個人化和有效的癌症護理。
  • 地理趨勢：放射治療市場預測顯示，北美因其先進的醫療基礎設施、高醫療支出和較早採用新技術而成為主導地區。該地區強大的監管框架和對癌症研究的大量投資也有助於其領先地位。此外，在醫療保健意識提高、癌症盛行率上升和醫療設施改善的推動下，亞太地區正在經歷快速成長。
  • 競爭格局：一些主要的放射治療公司包括 Accuray Incorporated、Becton Dickinson and Company、Eckert & Ziegler、Elekta AB (publ)、General Electric Company、Hitachi Ltd、Ion Beam Applications、Isoray Inc.、Mevion Medical Systems Inc.、Nordion Inc. (Sotera Health) 和西門子Healthineers AG (Siemens AG) 等。
  • 挑戰與機會：根據放射治療市場概況，放射治療系統和治療的高成本可能令許多患者和醫療保健系統望而卻步，這是市場成長的主要限制因素。然而，這項挑戰為放射治療市場提供了開發具有成本效益的治療模式和引入更合理技術的新機會。同時，在發展中市場擴大對臨床醫生的培訓和教育，以確保安全有效地使用先進的放射治療技術，正在對放射治療市場前景產生積極影響。

放射治療市場趨勢：

技術進步

放射治療市場的最新發展和創新，如調強放射治療（IMRT）和影像導引放射治療（IGRT），大大提高了癌症治療的精確度和有效性，有助於市場擴張。 IGRT 涉及在放射治療過程中使用即時成像，確保腫瘤被準確瞄準，即使治療之間存在移動。這使得腫瘤學家能夠在治療期間透過改變光束強度來調節輻射劑量，有效地使輻射劑量符合腫瘤的形狀，同時最大限度地減少對周圍健康組織的暴露。此外，2020年4月，國際原子能機構啟動了一個項目，研究立體定位放射治療（SFRT）如何增強肺癌和子宮頸癌的安寧療護，旨在減輕症狀並減緩疾病進展，這進一步有助於市場擴張。

人工智慧（AI）在放射治療中的整合

人工智慧技術被用來簡化規劃流程、提高輻射劑量的準確性並最佳化治療計劃。機器學習 (ML) 演算法可以分析成像和治療記錄的大型資料集，以識別模式並預測針對個別患者量身定做的最佳治療方法。人工智慧也被用來開發患者對各種放射治療反應的預測模型，該模型可用於適應性放射治療，根據患者對正在進行的治療的反應來調整治療。放射科醫生在 40 年內查看大約 225,000 次 MRI/CT 檢查，而人工智慧可以從 225,000 次掃描開始進行自我訓練，並在很短的時間內達到數百萬次掃描。這將簡化營運並將醫療保健服務擴展到更多人群，從而增加放射治療市場收入。

轉向個人化醫療

癌症治療對個人化醫療的日益轉變正在日益影響放射治療市場。個人化醫療方法涉及根據每個患者的個別特徵量身定做醫療治療，在放射治療的背景下，這意味著根據可能影響治療反應的遺傳、表現型和環境因素量身定做放射劑量和時間表。醫療保健提供者可以透過專注於個人化患者護理來減少不良副作用的發生率並提高治療效果。個人化醫療聯盟的報告顯示，2016年至2020年間，美國市場的個人化藥物數量增加了一倍。年的成長率為5%。

放射治療市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據類型、應用程式和最終用戶對市場進行了分類。

按類型分類：

  • 外束放射治療
    • 調強放射治療 (IMRT)
    • 影像導引放射治療 (IGRT)
    • 斷層放射治療
    • 立體定位放射外科
    • 立體定位放射治療
    • 質子治療
    • 3D 適形放射治療 (3D CRT)
    • 容積調製電弧療法 (VMAT)
  • 內部放射治療/近距離放射治療
  • 全身放射治療

外照射放射治療佔大部分市場佔有率

該報告根據類型提供了詳細的市場細分和分析。這包括外束放射治療（調強放射治療(IMRT)、影像導引放射治療(IGRT)、斷層放射治療、立體定位放射手術、立體定位身體放射治療、質子治療、3D 適形放射治療(3D CRT)和體積調製弧治療（VMAT））、內部放射治療/近距離放射治療和全身放射治療。根據該報告，體外放射治療佔最大部分。

根據放射治療市場分析，體外放射治療（EBRT）的多功能性和精確治療多種癌症的有效性推動了其需求的激增。與此一致的是，EBRT 仍然是最常見的放射治療形式，因為它能夠精確地以高能量束瞄準腫瘤，最大限度地減少對周圍健康組織的損害。此外，3D（3D）適形放射治療、調強放射治療（IMRT）和立體定位放射治療（SBRT）等技術先進系統的引入，大大增強了EBRT的吸引力，創造了積極的市場前景擴張。

按應用分類：

  • 皮膚癌和唇癌
  • 頭頸癌
  • 乳癌
  • 攝護腺癌
  • 子宮頸癌
  • 肺癌
  • 其他

乳癌佔產業最大佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括皮膚癌和唇癌、頭頸癌、乳癌、攝護腺癌、子宮頸癌、肺癌等。報告稱，乳癌佔最大的市場佔有率。

放射治療作為預防乳癌腫瘤復發的標準術後治療策略的功效是推動其市場需求的關鍵因素。根據世界衛生組織(WHO) 統計，到2022 年，全球有230 萬名女性被診斷出罹患乳癌，67 萬人死亡。全球乳癌發生率不斷上升，需要有效的治療方式，而放射治療因其在早期和晚期乳癌中的關鍵作用而得到認可。它對於早期乳癌的保存乳房特別有效，通常在腫瘤切除術後使用，以消除任何殘留的癌細胞並顯著降低癌症復發的風險。此外，放射治療還有助於緩解晚期轉移病例的症狀並控制腫瘤生長，這進一步增加了其需求。

按最終用戶分類：

  • 醫院
  • 癌症研究機構
  • 門診及放射治療中心

門診和放射治療中心代表了領先的細分市場

該報告提供了基於最終用戶的詳細市場細分和分析。這包括醫院、癌症研究機構以及門診和放射治療中心。根據該報告，門診和放射治療中心佔最大部分。

根據放射治療市場報告，門診和放射治療中心的需求是由對門診護理環境的日益偏好所推動的，與住院治療相比，門診護理環境提供成本效益、便利性並減輕患者負擔。門診護理中心特別有吸引力，因為它們使患者能夠接受高品質的專業護理，而無需住院過夜。此外，由於這些中心在管理放射治療等特定治療方面的專業和效率，通常可以比傳統醫院環境以更低的成本提供服務。這種成本效益吸引了尋求管理支出的患者和醫療保健付款人。此外，放射治療中心的激增和技術進步使複雜的放射治療設備變得更加緊湊和負擔得起，正在推動市場向前發展。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美市場處於領先地位，佔據最大的放射治療市場。

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是放射治療最大的區域市場。

北美對放射治療的需求受到多種因素的推動，例如完善的醫療基礎設施、癌症研究的雄厚資金以及癌症的高盛行率。北美擁有一些世界領先的癌症研究機構和醫院，它們採用並開發了尖端的放射治療技術。除此之外，該地區還受益於公共和私營部門的大量醫療保健支出，從而可以對先進醫療設備和治療方式進行大量投資。此外，人們非常關注早期癌症檢測和篩檢計劃，該計劃確定可以從放射治療早期干預中受益的患者，這正在推動市場成長。

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

  • 競爭格局的特徵是知名放射治療公司的存在，它們透過技術創新、併購、拓展新興市場等方式進行激烈競爭。他們正在開發具有更高精度和適應性的先進放射治療系統，並利用其廣泛的技術組合和強大的全球影響力來提高市場佔有率並滲透到新的地理區域。此外，專業公司還分別專注於近距離放射治療和緊湊型質子治療系統等利基技術，以提供滿足特定臨床需求並在市場上獲得競爭優勢的客製化解決方案。

放射治療市場新聞：

  • 2022 年 5 月，Elekta AB 推出了 Elekta Espirit，這是一款下一代伽瑪刀，可實現更個人化的放射外科手術。
  • 2023年5月，通用電氣公司推出了多種放射治療儀器，包括自動分割、智慧放射治療（IRT）和更新的MR放射治療套件。
  • 2023 年 9 月，西門子 Healthineers 收購了 Aspekt，以加強其放射腫瘤學服務。

本報告回答的關鍵問題：

  • 迄今為止，全球放射治療市場表現如何，未來幾年將如何表現？
  • 全球放射治療市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球放射治療市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的放射治療市場？
  • 依類型分類市場是怎麼樣的？
  • 放療市場上哪種類型最有吸引力？
  • 基於應用的市場區隔是什麼？
  • 放射治療市場中哪一個應用最具吸引力？
  • 基於最終用戶的市場區隔是什麼？
  • 放療市場上哪一個最有吸引力的最終用戶？
  • 市場競爭結構如何？
  • 誰是全球放射治療市場的主要參與者/公司

本報告回答的關鍵問題：

  • 迄今為止，全球放射治療市場表現如何，未來幾年將如何表現？
  • 全球放射治療市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球放射治療市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的放射治療市場？
  • 依類型分類市場是怎麼樣的？
  • 放療市場上哪種類型最有吸引力？
  • 基於應用的市場區隔是什麼？
  • 放射治療市場中哪一個應用最具吸引力？
  • 基於最終用戶的市場區隔是什麼？
  • 放療市場上哪一個最有吸引力的最終用戶？
  • 市場競爭結構如何？
  • 誰是全球放射治療市場的主要參與者/公司

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球放射治療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 外束放射治療
    • 市場趨勢
    • 關鍵環節
      • 調強放射治療 (IMRT)
      • 影像導引放射治療 (IGRT)
      • 斷層放射治療
      • 立體定位放射外科
      • 立體定位放射治療
      • 質子治療
      • 3D 適形放射治療 (3D CRT)
      • 容積調製電弧療法 (VMAT)
    • 市場預測
  • 內部放射治療/近距離放射治療
    • 市場趨勢
    • 市場預測
  • 全身放射治療
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按應用

  • 皮膚癌和唇癌
    • 市場趨勢
    • 市場預測
  • 頭頸癌
    • 市場趨勢
    • 市場預測
  • 乳癌
    • 市場趨勢
    • 市場預測
  • 攝護腺癌
    • 市場趨勢
    • 市場預測
  • 子宮頸癌
    • 市場趨勢
    • 市場預測
  • 肺癌
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場趨勢
    • 市場預測
  • 癌症研究機構
    • 市場趨勢
    • 市場預測
  • 門診及放射治療中心
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Accuray Incorporated
    • Becton Dickinson and Company
    • Eckert & Ziegler
    • Elekta AB (publ)
    • General Electric Company
    • Hitachi Ltd
    • Ion Beam Applications
    • Isoray Inc.
    • Mevion Medical Systems Inc.
    • Nordion Inc. (Sotera Health)
    • Siemens Healthineers AG (Siemens AG)
Product Code: SR112024A4413

The global radiotherapy market size reached US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032. The rise in cancer incidence, advancements in technology, increasing precision in tumor targeting, growing healthcare expenditure, and heightened awareness of radiotherapy's benefits as a non-invasive cancer treatment option are some of the factors creating a positive outlook for the market growth.

Radiotherapy Market Analysis:

  • Major Market Drivers: The market for radiotherapy is primarily driven by the rising incidence of cancer worldwide, which is creating a demand for non-invasive, efficient treatment options. Besides this, the increased healthcare spending and improvements in healthcare infrastructure in the developing region, where access to advanced radiation treatments is more available, are bolstering the radiotherapy demand.
  • Key Market Trends: Technological advancements in radiotherapy devices, such as the development of intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT), represent one of the major radiotherapy market trends. Concurrently, the integration of artificial intelligence (AI) in radiotherapy improving treatment planning and delivery is another emerging trend leading to more personalized and effective cancer care.
  • Geographical Trends: The radiotherapy market forecast revealed North America as the dominating region due to its advanced healthcare infrastructure, high healthcare expenditure, and early adoption of new technologies. The region's strong regulatory framework and substantial investments in cancer research also contribute to its leading position. Furthermore, Asia Pacific is experiencing rapid growth, driven by increasing healthcare awareness, rising cancer prevalence, and improving healthcare facilities.
  • Competitive Landscape: Some of the major radiotherapy companies are Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB (publ), General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health) and Siemens Healthineers AG (Siemens AG) among many others.
  • Challenges and Opportunities: According to the radiotherapy market overview, the high cost of radiotherapy systems and treatments, which can be prohibitive for many patients and healthcare systems, is a major constraint for the market growth. However, this challenge presents the radiotherapy market with recent opportunities for the development of cost-effective treatment models and the introduction of more reasonable technology. Along with this, the expansion of training and education for clinicians in developing markets to ensure the safe and effective use of advanced radiotherapy technologies is positively impacting the radiotherapy market outlook.

Radiotherapy Market Trends:

Technological advancements

Radiotherapy market recent developments and innovations such as intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) have greatly improved the precision and effectiveness of cancer treatments, aiding in market expansion. IGRT involves the use of real-time imaging during radiation therapy sessions, ensuring that the tumor is accurately targeted, even if there is movement between treatments. This allows oncologists to modulate the radiation dose by varying the beam intensity during treatment, effectively conforming the radiation dose to the shape of the tumor while minimizing exposure to surrounding healthy tissues. Moreover, in April 2020, the IAEA started a project to study how Stereotactic Fractionated Radiotherapy (SFRT) can enhance palliative treatment for lung and cervical cancers, aiming to alleviate symptoms and slow down disease progression, which is further aiding in market expansion.

Integration of artificial intelligence (AI) in radiotherapy

AI technologies are being used to streamline the planning process, improve the accuracy of radiation dosing, and optimize treatment schedules. Machine learning (ML) algorithms can analyze large datasets of imaging and treatment records to identify patterns and predict optimal treatment approaches tailored to individual patients. AI is also being utilized to develop predictive models for patient responses to various radiation therapies, which can be used in adaptive radiotherapy to adjust treatments based on the patient's response to ongoing sessions. Radiologists look at approximately 225,000 MRI/CT exams in 40 years, while AI can start with 225,000 scans to train itself and reach millions of scans within a very short period of time. This will streamline operations and expand healthcare services to a larger population, thereby boosting radiotherapy market revenue.

Shift toward personalized medicine

The growing shift towards personalized medicine in cancer treatment is increasingly influencing the radiotherapy market. Personalized medicine approaches involve tailoring medical treatment to the individual characteristics of each patient, and in the context of radiotherapy, this means customizing radiation doses and schedules based on genetic, phenotypic, and environmental factors that could affect treatment response. Healthcare providers can reduce the incidence of unfavorable side effects and increase treatment efficacy by concentrating on individualized patient care. The Personalized Medicine Coalition's report indicates that the number of personalized medicines in the US market doubled between 2016 and 2020. These medicines, which accounted for 25% of new drugs approved by the FDA in 2019, rose from 132 to 286, marking a significant increase from 5% in 2005. This growth is boosting the radiotherapy market share.

Radiotherapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, application, and end user.

Breakup by Type:

  • External Beam Radiation Therapy
    • Intensity-Modulated Radiation Therapy (IMRT)
    • Image-Guided Radiation Therapy (IGRT)
    • Tomotherapy
    • Stereotactic Radiosurgery
    • Stereotactic Body Radiation Therapy
    • Proton Therapy
    • 3D Conformal Radiotherapy (3D CRT)
    • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Radiation Therapy/Brachytherapy
  • Systemic Radiation Therapy

External beam radiation therapy accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes external beam radiation therapy (intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), tomotherapy, stereotactic radiosurgery, stereotactic body radiation therapy, proton therapy, 3D conformal radiotherapy (3D CRT), and volumetric modulated arc therapy (VMAT)), internal radiation therapy/brachytherapy and systemic radiation therapy. According to the report, external beam radiation therapy represented the largest segment.

Based on the radiotherapy market analysis, the surging demand for external beam radiation therapy (EBRT) is driven by its versatility and effectiveness in treating a wide range of cancers with precision. In line with this, EBRT remains the most common form of radiotherapy due to its ability to accurately target tumors with high-energy beams, minimizing damage to surrounding healthy tissues. Furthermore, the introduction of technologically advanced systems like three-dimensional (3D) conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and stereotactic body radiation therapy (SBRT) has greatly enhanced the appeal of EBRT, creating a positive outlook for market expansion.

Breakup by Application:

  • Skin and Lip Cancer
  • Head and Neck Cancer
  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others

Breast cancer holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others. According to the report, breast cancer accounted for the largest market share.

Radiotherapy's efficacy as a standard post-operative therapeutic strategy to prevent tumor recurrence in breast cancer represents a crucial factor driving its market demand. According to the World Health Organization (WHO), there were 2.3 million women diagnosed with breast cancer and 670,000 deaths globally in 2022. This increasing incidence of breast cancer globally necessitates effective treatment modalities, and radiotherapy is recognized for its critical role in the early and advanced stages of the disease. It is particularly effective in conserving the breast in cases of early-stage breast cancer, often used following lumpectomy to eliminate any remaining cancerous cells and significantly reduce the risk of cancer returning. Additionally, radiotherapy also helps alleviate symptoms and control tumor growth in advanced metastatic cases, which is further boosting its demand.

Breakup by End User:

  • Hospitals
  • Cancer Research Institutes
  • Ambulatory and Radiotherapy Centers

Ambulatory and radiotherapy centers represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, cancer research institutes, and ambulatory and radiotherapy centers. According to the report, ambulatory and radiotherapy centers represented the largest segment.

As per the radiotherapy market report, its demand in ambulatory and radiotherapy centers is driven by an increasing preference for outpatient care settings, which offer cost-efficiency, convenience, and reduced patient burden compared to in-hospital treatments. Ambulatory care centers are particularly appealing because they enable patients to receive high-quality, specialized care without the need for overnight hospital stays. Additionally, these centers can often provide services at a lower cost than traditional hospital settings due to their specialized nature and efficiency in managing specific treatments like radiotherapy. This cost-effectiveness attracts patients and healthcare payers seeking to manage expenditures. Furthermore, the proliferation of radiotherapy centers and technological advancements that make sophisticated radiotherapy equipment more compact and affordable, are propelling the market forward.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest radiotherapy market share.

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for radiotherapy.

The demand for radiotherapy in North America is propelled by numerous factors such as well-established healthcare infrastructure, robust funding for cancer research, and the high prevalence of cancer. North America boosts some of the world's leading cancer research facilities and hospitals, which adopt and also develop cutting-edge radiotherapy technologies. In addition to this, the region benefits from substantial healthcare spending both from the public and private sectors, allowing for significant investments in advanced medical equipment and treatment modalities. Furthermore, there is a strong focus on early cancer detection and screening programs, which identify patients who can benefit from early intervention using radiotherapy, which is impelling the market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the radiotherapy industry include Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB (publ), General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health), Siemens Healthineers AG (Siemens AG), etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The competitive landscape is characterized by the presence of prominent radiotherapy companies who are engaged in fierce competition through technological innovation, mergers, and acquisitions, and expansion into emerging markets. They are developing advanced radiotherapy systems with enhanced precision and adaptability and leveraging their broad technological portfolios and strong global presence to enhance their market share and penetrate new geographical regions. Additionally, specialized companies are focusing on niche technologies like brachytherapy and compact proton therapy systems, respectively to offer tailored solutions that meet specific clinical needs and gain a competitive edge in the market.

Radiotherapy Market News:

  • In May 2022, Elekta AB launched Elekta Espirit, a next-generation gamma knife that enables more personalized radiosurgery.
  • In May 2023, General Electric Company launched multiple radiotherapy instruments, including auto segmentation, intelligent radiation therapy (IRT), and an updated MR radiation therapy suite.
  • In September 2023, Siemens Healthineers acquired Aspekt to strengthen its radiation oncology services.

Key Questions Answered in This Report:

  • How has the global radiotherapy market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global radiotherapy market?
  • What is the impact of each driver, restraint, and opportunity on the global radiotherapy market?
  • What are the key regional markets?
  • Which countries represent the most attractive radiotherapy market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the radiotherapy market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the radiotherapy market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the radiotherapy market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global radiotherapy market

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiotherapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Intensity-Modulated Radiation Therapy (IMRT)
      • 6.1.2.2 Image-Guided Radiation Therapy (IGRT)
      • 6.1.2.3 Tomotherapy
      • 6.1.2.4 Stereotactic Radiosurgery
      • 6.1.2.5 Stereotactic Body Radiation Therapy
      • 6.1.2.6 Proton Therapy
      • 6.1.2.7 3D Conformal Radiotherapy (3D CRT)
      • 6.1.2.8 Volumetric Modulated Arc Therapy (VMAT)
    • 6.1.3 Market Forecast
  • 6.2 Internal Radiation Therapy/Brachytherapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Systemic Radiation Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Skin and Lip Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Head and Neck Cancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Breast Cancer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Prostate Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cervical Cancer
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Lung Cancer
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cancer Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory and Radiotherapy Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accuray Incorporated
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Eckert & Ziegler
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Elekta AB (publ)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 General Electric Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hitachi Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Ion Beam Applications
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Isoray Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Mevion Medical Systems Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Nordion Inc. (Sotera Health)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Siemens Healthineers AG (Siemens AG)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Radiotherapy Market: Major Drivers and Challenges
  • Figure 2: Global: Radiotherapy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Radiotherapy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Radiotherapy Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Radiotherapy Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Radiotherapy Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Radiotherapy Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Radiotherapy (External Beam Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Radiotherapy (External Beam Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Radiotherapy (Internal Radiation Therapy/Brachytherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Radiotherapy (Internal Radiation Therapy/Brachytherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Radiotherapy (Systemic Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Radiotherapy (Systemic Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Radiotherapy (Skin and Lip Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Radiotherapy (Skin and Lip Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Radiotherapy (Head and Neck Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Radiotherapy (Head and Neck Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Radiotherapy (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Radiotherapy (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Radiotherapy (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Radiotherapy (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Radiotherapy (Cervical Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Radiotherapy (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Radiotherapy (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Radiotherapy (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Radiotherapy (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Radiotherapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Radiotherapy (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Radiotherapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Radiotherapy (Cancer Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Radiotherapy (Cancer Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Radiotherapy (Ambulatory and Radiotherapy Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Radiotherapy (Ambulatory and Radiotherapy Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia-Pacific: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia-Pacific: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: Radiotherapy Market: Breakup by Country (in %), 2023
  • Figure 82: Middle East and Africa: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Global: Radiotherapy Industry: SWOT Analysis
  • Figure 84: Global: Radiotherapy Industry: Value Chain Analysis
  • Figure 85: Global: Radiotherapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiotherapy Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Radiotherapy Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Radiotherapy Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Radiotherapy Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Radiotherapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Radiotherapy Market: Competitive Structure
  • Table 7: Global: Radiotherapy Market: Key Players